这种情况就是说黑色素细胞因遭到免疫系统攻击而变得虚弱,从而无法产生黑素。
There is an autoimmune condition called vitiligo in which melanocytes are attacked by the immune system and become too weak to produce melanin.
罗氏公司的vemurafenib通过阻断一种突变的基因b - raf攻击晚期黑色素瘤。
Roche's vemurafenib attacks advanced melanoma by blocking the mutated form of a gene, B-RAF.
“我们中的许多人认为,包含了免疫系统攻击癌细胞的这一联合治疗方法,最终将被证明对控制癌症最有效,如恶性黑色素瘤”,他说。
"Many of us believe that a combined approach that includes an immune system attack on cancer cells will ultimately prove to be most useful in controlling cancers such as melanoma," he tells WebMD.
应用推荐